文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

前列腺床放疗后的复发模式

Patterns of recurrence after prostate bed radiotherapy.
PubMed 文献 · Radiother Oncol · 2019-09-25

该研究回顾了1997至2013年在皇家马斯登医院接受前列腺床放疗的男性患者,分析放疗后影像学失败的模式。322例中140例出现生化失败,89例有影像学失败,其中35例(39%)仅为盆腔淋巴结失败而无远处病变,且PSA高于或低于0.34 ng/ml的患者盆腔淋巴结失败率相同。结论提示盆腔淋巴结是常见失败部位,支持将盆腔淋巴结纳入放疗体积。

要点

  • 前列腺床放疗后影像学失败者中39%为单纯盆腔淋巴结失败。
  • PSA高于或低于0.34 ng/ml者盆腔淋巴结失败率无差异。
  • 结果支持将盆腔淋巴结纳入前列腺床放疗靶区。

核心结论

  • 盆腔淋巴结病变而无更远处病变是前列腺床放疗后常见失败部位,包括PSA低于0.34 ng/ml的患者。

研究设计与样本

  • 回顾性分析1997至2013年皇家马斯登医院接受前列腺床放疗的男性患者,共322例。

主要发现

  • 322例中140例挽救性放疗后出现生化失败。
  • 89例出现影像学失败,其中35例(39%)为盆腔淋巴结失败而无远处病变。
  • 盆腔淋巴结失败患者与其他复发模式患者的基线特征无显著差异。
  • PSA高于或低于0.34 ng/ml者的盆腔淋巴结失败率相同:16/149(95%CI 6-17%) vs 19/171(95%CI 7-17%)。

关键数值与推荐

  • 比较采用卡方检验,多重检验校正后p<0.005为显著。

临床怎么用

  • 前列腺床放疗时需考虑盆腔淋巴结预防照射,即使PSA低于0.34 ng/ml。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Prostate bed radiotherapy is a standard treatment after radical prostatectomy. Recent evidence suggests that, for patients with a PSA > 0.34 ng/ml, the radiotherapy treatment volume should include not only the prostate bed but also the pelvic lymph nodes. We describe the patterns of failure after prostate bed radiotherapy, focussing on the proportion of patients with radiologically confirmed pelvic nodal failure only, in the absence of distant disease. MATERIALS AND METHODS: Patients included were men receiving prostate bed radiotherapy at the Royal Marsden Hospital between 1997 and 2013. The key outcome of interest was the pattern of radiologic failure after prostate bed radiotherapy. Baseline characteristics of patients experiencing pelvic nodal failure without distant disease were compared versus all other relapse patterns. Comparisons were by Chi-square test, with multiple testing adjusted p < 0.005 significant. RESULTS: 140 of 322 patients developed biochemical failure after salvage RT. Radiologic failure occurred in 89 patients. 35 of the 89 patients (39%) with radiologic failure had pelvic nodal failure without distant disease, with no significant differences in baseline characteristics when compared to all other patients. The rate of pelvic nodal failure was the same for patients with PSA above or below 0.34 ng/ml (16/149, 95% CI = 6-17% vs 19/171, 95% CI = 7-17%). CONCLUSIONS: Pelvic lymph node disease, without more distant disease, is a common site of failure in men receiving radiotherapy to the prostate bed, including those with PSA < 0.34 ng/ml. This observation informs the case for including the pelvic lymph nodes in the radiotherapy treatment volume.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Brand DH, Parker JI, Dearnaley DP, et al. Patterns of recurrence after prostate bed radiotherapy. Radiother Oncol. 2019. PMID: 31563410. doi:10.1016/j.radonc.2019.09.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。